Profile data is unavailable for this security.
About the company
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
- Revenue in CAD (TTM)54.86m
- Net income in CAD-29.77m
- Incorporated2003
- Employees80.00
- LocationValeo Pharma Inc16667 Hymus BlvdKIRKLAND H9H 4R9CanadaCAN
- Phone+1 (514) 693-8832
- Fax+1 (514) 693-8832
- Websitehttps://valeopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indiva Ltd | 37.49m | -4.44m | 5.86m | 142.00 | -- | -- | -- | 0.1564 | -0.0248 | -0.0248 | 0.2093 | -0.0066 | 0.9948 | 6.15 | 8.59 | -- | -11.77 | -29.67 | -39.98 | -48.24 | 29.21 | 20.37 | -11.83 | -48.06 | 0.4471 | -0.4265 | 1.06 | -- | 9.21 | 264.60 | 55.01 | -- | -33.00 | -- |
Voyageur Pharmaceuticals Ltd | 0.00 | -1.35m | 8.37m | -- | -- | 5.29 | -- | -- | -0.0101 | -0.0101 | 0.00 | 0.0114 | 0.00 | -- | -- | -- | -50.78 | -74.47 | -69.30 | -120.92 | -- | -- | -- | -- | 0.4715 | -290.54 | 0.0248 | -- | -- | -- | 20.21 | -- | -11.81 | -- |
Khiron Life Sciences Corp | 16.14m | -30.66m | 9.30m | 310.00 | -- | -- | -- | 0.5761 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
Valeo Pharma Inc | 54.86m | -29.77m | 9.87m | 80.00 | -- | -- | -- | 0.1799 | -0.3273 | -0.3273 | 0.6054 | -0.5561 | 1.32 | 4.45 | 9.31 | 438,864.00 | -71.78 | -64.35 | -330.86 | -113.22 | 18.32 | 23.88 | -54.26 | -69.71 | 0.2738 | -1.31 | 5.32 | -- | 94.31 | 65.20 | -8.01 | -- | 76.61 | -- |
Crescita Therapeutics Inc | 17.92m | -2.34m | 9.92m | 78.00 | -- | 0.5493 | -- | 0.5534 | -0.1162 | -0.1162 | 0.8927 | 0.9285 | 0.6903 | 1.50 | 4.62 | -- | -9.01 | -0.2457 | -11.40 | -0.3059 | 56.03 | 63.41 | -13.06 | -0.3518 | 2.60 | -- | 0.0594 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
Data as of Jul 05 2024. Currency figures normalised to Valeo Pharma Inc's reporting currency: Canadian Dollar CAD